Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study

Arthritis Care and Research

Volumn 64, Issue 3, 2012, Pages 384-388

  Rome, Keith ^a   Frecklington, Mike ^a   McNair, Peter ^a   Gow, Peter ^b   Dalbeth, Nicola ^b  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; URATE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISABILITY; FEMALE; FOOT PAIN; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; NEW ZEALAND; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUESTIONNAIRE; VISUAL ANALOG SCALE;

ADULT; AGED; DISABILITY EVALUATION; FEMALE; FOOT; GOUT; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84859832779     PISSN: 00043591     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20670     Document Type: Article

References (31)

1. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008;67:960-6.
2. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population. Arthritis Rheum 2011; 63:3136-41.
3. Klemp P, Stansfield SA, Castle B, Robertson MB. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-6.
4. Winnard D, Wright C, Taylor W, Jackson G, Te Karu L, Gow P, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012. E-pub ahead of print.
5. Grahame R, Scott JT. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970;29:461-8.
6. Garcia CO, Kutzbach A, Espinoza LR. Characteristics of gouty arthritis in the Guatemalan population. Clin Rheumatol 1997; 16:45-50.
7. Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford) 2009;48 Suppl 2:ii2-8.
8. Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis 2007;66:1374-7.
9. Kleinman NL, Brook RA, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE. The impact of gout on work absence and productivity. Value Health 2008;10:231-7.
10. Edwards NL, Sundy JS, Forsythe A, Blume S, Pan F, Becker MA. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ 2011;14:10-5.
11. Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009;36:865-8.
12. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol 2011;23:192-202.
13. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
14. Ten Klooster PM, Oude Voshaar MA, Taal E, van der Laar MA. Comparison of measures of functional disability in patients with acute gout. Rheumatology (Oxford) 2011;50:709-13.
15. Wolfe F, Michaud K, Pincus T. Development and validation of the Health Assessment Questionnaire II. Arthritis Rheum 2004;50:3296-305.
16. Platto MJ, O'Connell PG, Hicks JE, Gerber LH. The relationship of pain and deformity of the rheumatoid foot to gait and an index of functional ambulation. J Rheumatol 1991;18:38-43.
17. Redmond AC, Crane YZ, Menz HB. Normative values for the foot posture index. J Foot Ankle Res 2008;1:6.
18. Helliwell P, Reay N, Gilworth G, Redmond A, Slade A, Tennant A, et al. Development of a foot impact scale for rheumatoid arthritis. Arthritis Rheum 2005;53:418-22.
19. World Health Organization. International classification of functioning, disability and health (ICF). Geneva: World Health Organization; 2001.
20. Turner DE, Helliwell PS, Emery P, Woodburn J. The impact of rheumatoid arthritis on foot function in the early stages of disease: a clinical case series. BMC Musculskelet Disord 2006; 7:102.
21. McNair PJ, Prapavessis H, Collier J, Bassett S, Bryant A, Larmer P. The lower-limb tasks questionnaire: an assessment of validity, reliability, responsiveness, and minimal important differences. Arch Phys Med Rehabil 2007;88:993-1001.
22. Schlesinger N, Dalbeth N, Perez-Ruiz F. Gout: what are the treatment options? Expert Opin Pharmacother 2009;10:1319-28.
23. Logan JA, Morrison E, McGill PK. Serum uric acid in acute gout [letter]. Ann Rheum Dis 1997;56:696-7.
24. Schlesinger N, Baker DG, Schumacher HR Jr. Serum urate during bouts of acute gouty arthritis [letter]. J Rheumatol 1997;24:2265-6.
25. Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout. Arthritis Rheum 2004;50: 598-606.
26. Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet 2008;371:1854-60.
27. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2011;17:1-6.
28. Rome K, Survepalli D, Sanders A, Lobo M, McQueen FM, McNair PJ, et al. Functional and biomechanical characteristic of foot disease in chronic gout: a case-control study. Clin Biomech (Bristol, Avon) 2010;26:90-4.
29. Reid DA, McNair PJ. Effects of a six week lower limb stretching programme on range of motion, peak passive torque and stiffness in people with and without osteoarthritis of the knee. N Z J Phys 2011;39:5-12.
30. Hutton I, Gamble G, Gow P, Dalbeth N. Factors associated with recurrent hospital admissions for gout. J Clin Rheumatol 2009;15:271-4.
31. Dalbeth N, Kumar S, Stamp L, Gow P. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol 2006;33:1646-50.